CD44 and urinary bladder carcinoma: In addition, we found that ITPR3 accelerated the malignant progression of bladder cancer by promoting proliferation, metastasis, and cancer stemness in vitro and in vivo, and in this process, the role of the NF-κB/CD44 signaling pathway could not be neglected.